Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,410,220 | 17,435,540 | 8,418,519 | 8,051,906 | N/A |
| Receivables | 580,943 | 9,316,587 | 470,915 | 9,090,722 | N/A |
| Inventories | 28,639,220 | 10,918,350 | 23,018,970 | 10,205,290 | N/A |
| Other current assets | 161,317 | 4,351,223 | 14,465,617 | 18,736,562 | 0 |
| TOTAL | $39,791,700 | $42,021,700 | $46,374,020 | $46,084,480 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 11,335,990 | 10,868,410 | 10,344,320 | 10,919,470 | N/A |
| Investments And Advances | 0 | 4,044,718 | 0 | 341,944 | 0 |
| Intangibles | 80,498,630 | 68,922,530 | 67,222,780 | 71,432,670 | 0 |
| Other Non-Current Assets | 20,089,880 | 15,996,102 | 15,007,100 | 14,922,156 | 0 |
| TOTAL | $111,924,500 | $99,831,760 | $92,574,200 | $97,616,240 | $N/A |
| Total Assets | $151,716,200 | $141,853,500 | $138,948,200 | $143,700,700 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,587,317 | 8,297,177 | 7,765,349 | 4,554,559 | N/A |
| Accounts payable and accrued liabilities | 25,715,800 | 8,031,540 | 22,772,460 | 8,170,937 | 0 |
| Other current liabilities | N/A | 15,548,830 | N/A | 15,488,100 | N/A |
| TOTAL | $37,527,540 | $32,987,780 | $33,944,820 | $31,556,200 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,676,130 | 14,984,640 | 12,396,530 | 12,759,040 | N/A |
| Other Non-Current Liabilities | 12,627,629 | 12,148,911 | 12,010,963 | 12,780,139 | -31,888 |
| TOTAL | $28,235,950 | $29,084,960 | $26,604,040 | $27,895,460 | $N/A |
| Total Liabilities | $65,763,480 | $62,072,730 | $60,548,860 | $59,451,660 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | N/A | 2,788,051 | N/A | 2,733,385 | N/A |
| Retained earnings | N/A | 74,570,160 | N/A | 73,782,990 | N/A |
| Other shareholders' equity | 85,952,730 | 3,517,022 | 78,399,360 | 8,641,685 | 0 |
| TOTAL | $85,952,730 | $79,780,720 | $78,399,360 | $84,249,060 | $N/A |
| Total Liabilities And Equity | $151,716,210 | $141,853,450 | $138,948,220 | $143,700,720 | $0 |